Impact of total neoadjuvant therapy consisting of consolidation chemotherapy on locally advanced rectal cancer survival View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-06-18

AUTHORS

Haoyu Zhang, Ganbin Li, Ke Cao, Zhiwei Zhai, Guanghui Wei, Hao Qu, Zhenjun Wang, Jiagang Han

ABSTRACT

PurposeThe objective was to compare disease-free survival (DFS) and distant metastasis in patients with neoadjuvant chemoradiotherapy (NCRT) and total neoadjuvant therapy (TNT) for locally advanced rectal cancer.MethodsPatients with cT3-4N0M0 or cTxN1-2M0 rectal cancer were included in this retrospective study. Patients who received NCRT (radiotherapy with concurrent capecitabine) or TNT (radiotherapy with two concurrent cycles of capecitabine and oxaliplatin (CAPOX) followed by another two cycles of CAPOX) during January 2011 and November 2016 at Beijing Chaoyang Hospital, Capital Medical University were included. All patients had received radical surgery. Adverse events, pathological response and survival outcomes in the two groups were compared.ResultsOne hundred eighty-two patients were enrolled, 120 in the TNT and 62 in the NCRT groups. No significant between-group differences in neoadjuvant therapy-associated adverse events or surgical complications were found. TNT achieved a higher pathological complete response (pCR) rate (25.8%) compared with NCRT (12.9%, P = 0.044). Patients in the TNT group had a higher 3-year DFS rate (82.8% versus 75.7%, P = 0.041) and lower distant metastasis rate (19.2% versus 33.1%, P = 0.049) than those in the NCRT group. Multivariate analysis showed that NCRT was an independent risk factor for DFS (95%CI 2.023–13.415, P = 0.001) and distant metastasis (95% CI 2.149–20.082, P = 0.001).ConclusionWith similar adverse events and a higher pCR rate when compared with NCRT, TNT might be considered as a safe and effective therapeutic strategy to improve prognosis in patients with locally advanced rectal cancer. More... »

PAGES

1657-1668

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00384-022-04179-7

DOI

http://dx.doi.org/10.1007/s00384-022-04179-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1148785393

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35716183


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Capecitabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemoradiotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Consolidation Chemotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Second Primary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxaliplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.411607.5", 
          "name": [
            "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Haoyu", 
        "id": "sg:person.016147501475.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016147501475.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.411607.5", 
          "name": [
            "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Ganbin", 
        "id": "sg:person.011747070467.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011747070467.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.411607.5", 
          "name": [
            "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cao", 
        "givenName": "Ke", 
        "id": "sg:person.013577637100.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013577637100.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.411607.5", 
          "name": [
            "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhai", 
        "givenName": "Zhiwei", 
        "id": "sg:person.0765051075.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765051075.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.411607.5", 
          "name": [
            "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wei", 
        "givenName": "Guanghui", 
        "id": "sg:person.01155207276.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155207276.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.411607.5", 
          "name": [
            "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Qu", 
        "givenName": "Hao", 
        "id": "sg:person.01260414050.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260414050.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.411607.5", 
          "name": [
            "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Zhenjun", 
        "id": "sg:person.011500603034.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011500603034.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China", 
          "id": "http://www.grid.ac/institutes/grid.411607.5", 
          "name": [
            "Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Han", 
        "givenName": "Jiagang", 
        "id": "sg:person.01034306452.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034306452.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1245/s10434-010-0985-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033481932", 
          "https://doi.org/10.1245/s10434-010-0985-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-06-18", 
    "datePublishedReg": "2022-06-18", 
    "description": "PurposeThe objective was to compare disease-free survival (DFS) and distant metastasis in patients with neoadjuvant chemoradiotherapy (NCRT) and total neoadjuvant therapy (TNT) for locally advanced rectal cancer.MethodsPatients with cT3-4N0M0 or cTxN1-2M0 rectal cancer were included in this retrospective study. Patients who received NCRT (radiotherapy with concurrent capecitabine) or TNT (radiotherapy with two concurrent cycles of capecitabine and oxaliplatin (CAPOX) followed by another two cycles of CAPOX) during January 2011 and November 2016 at Beijing Chaoyang Hospital, Capital Medical University were included. All patients had received radical surgery. Adverse events, pathological response and survival outcomes in the two groups were compared.ResultsOne hundred eighty-two patients were enrolled, 120 in the TNT and 62 in the NCRT groups. No significant between-group differences in neoadjuvant therapy-associated adverse events or surgical complications were found. TNT achieved a higher pathological complete response (pCR) rate (25.8%) compared with NCRT (12.9%, P\u2009=\u20090.044). Patients in the TNT group had a higher 3-year DFS rate (82.8% versus 75.7%, P\u2009=\u20090.041) and lower distant metastasis rate (19.2% versus 33.1%, P\u2009=\u20090.049) than those in the NCRT group. Multivariate analysis showed that NCRT was an independent risk factor for DFS (95%CI 2.023\u201313.415, P\u2009=\u20090.001) and distant metastasis (95% CI 2.149\u201320.082, P\u2009=\u20090.001).ConclusionWith similar adverse events and a higher pCR rate when compared with NCRT, TNT might be considered as a safe and effective therapeutic strategy to improve prognosis in patients with locally advanced rectal cancer.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00384-022-04179-7", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096381", 
        "issn": [
          "0179-1958", 
          "1432-1262"
        ], 
        "name": "International Journal of Colorectal Disease", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "keywords": [
      "total neoadjuvant therapy", 
      "disease-free survival", 
      "neoadjuvant chemoradiotherapy", 
      "advanced rectal cancer", 
      "adverse events", 
      "rectal cancer", 
      "nCRT group", 
      "neoadjuvant therapy", 
      "distant metastasis", 
      "higher pathological complete response rate", 
      "therapy-associated adverse events", 
      "pathological complete response rate", 
      "complete response rate", 
      "Beijing Chaoyang Hospital", 
      "independent risk factor", 
      "distant metastasis rate", 
      "Capital Medical University", 
      "similar adverse events", 
      "ResultsOne hundred eighty", 
      "effective therapeutic strategy", 
      "rectal cancer survival", 
      "DFS rates", 
      "consolidation chemotherapy", 
      "Chaoyang Hospital", 
      "radical surgery", 
      "surgical complications", 
      "metastasis rate", 
      "retrospective study", 
      "survival outcomes", 
      "cancer survival", 
      "risk factors", 
      "pathological response", 
      "therapeutic strategies", 
      "patients", 
      "response rate", 
      "multivariate analysis", 
      "Medical University", 
      "PurposeThe objective", 
      "cancer", 
      "group differences", 
      "metastasis", 
      "therapy", 
      "TNT group", 
      "survival", 
      "group", 
      "chemoradiotherapy", 
      "MethodsPatients", 
      "complications", 
      "chemotherapy", 
      "surgery", 
      "prognosis", 
      "hospital", 
      "rate", 
      "outcomes", 
      "events", 
      "response", 
      "factors", 
      "differences", 
      "study", 
      "objective", 
      "strategies", 
      "impact", 
      "eighties", 
      "analysis", 
      "University"
    ], 
    "name": "Impact of total neoadjuvant therapy consisting of consolidation chemotherapy on locally advanced rectal cancer survival", 
    "pagination": "1657-1668", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1148785393"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00384-022-04179-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35716183"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00384-022-04179-7", 
      "https://app.dimensions.ai/details/publication/pub.1148785393"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_951.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00384-022-04179-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00384-022-04179-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00384-022-04179-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00384-022-04179-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00384-022-04179-7'


 

This table displays all metadata directly associated to this object as RDF triples.

223 TRIPLES      21 PREDICATES      102 URIs      93 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00384-022-04179-7 schema:about N0d00714fc9194045a38ab9c28396a6cc
2 N12892dfaaf4f49208f2a59760cd0abfa
3 N25eacae1ec7143ecaacf665f820b1131
4 N2d0eaecd772d40a794cc61138819a6bf
5 N31cc1f5a38234860a9167cc58640e3c5
6 N423681b16ee248cd91a7cb2394f0d13f
7 N52936efc2d2547fdb3fbfbb6a23d1e65
8 N8b7a7c22982942b58ae175ad5c5d113c
9 Na2a9cc75d9a6430f849861d855cd6a30
10 Nb747f9d7e39542b794939c4c650aedc9
11 Nc6025b392ef24e929f75414f4a626b98
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author N028ed16a9be3426fb1a6dda63d0bbfcc
15 schema:citation sg:pub.10.1245/s10434-010-0985-4
16 schema:datePublished 2022-06-18
17 schema:datePublishedReg 2022-06-18
18 schema:description PurposeThe objective was to compare disease-free survival (DFS) and distant metastasis in patients with neoadjuvant chemoradiotherapy (NCRT) and total neoadjuvant therapy (TNT) for locally advanced rectal cancer.MethodsPatients with cT3-4N0M0 or cTxN1-2M0 rectal cancer were included in this retrospective study. Patients who received NCRT (radiotherapy with concurrent capecitabine) or TNT (radiotherapy with two concurrent cycles of capecitabine and oxaliplatin (CAPOX) followed by another two cycles of CAPOX) during January 2011 and November 2016 at Beijing Chaoyang Hospital, Capital Medical University were included. All patients had received radical surgery. Adverse events, pathological response and survival outcomes in the two groups were compared.ResultsOne hundred eighty-two patients were enrolled, 120 in the TNT and 62 in the NCRT groups. No significant between-group differences in neoadjuvant therapy-associated adverse events or surgical complications were found. TNT achieved a higher pathological complete response (pCR) rate (25.8%) compared with NCRT (12.9%, P = 0.044). Patients in the TNT group had a higher 3-year DFS rate (82.8% versus 75.7%, P = 0.041) and lower distant metastasis rate (19.2% versus 33.1%, P = 0.049) than those in the NCRT group. Multivariate analysis showed that NCRT was an independent risk factor for DFS (95%CI 2.023–13.415, P = 0.001) and distant metastasis (95% CI 2.149–20.082, P = 0.001).ConclusionWith similar adverse events and a higher pCR rate when compared with NCRT, TNT might be considered as a safe and effective therapeutic strategy to improve prognosis in patients with locally advanced rectal cancer.
19 schema:genre article
20 schema:isAccessibleForFree false
21 schema:isPartOf N17212bc36b0440d7a2b4a3c53ba50614
22 Ndaf8e282cca7423183f2d677ef1a41dc
23 sg:journal.1096381
24 schema:keywords Beijing Chaoyang Hospital
25 Capital Medical University
26 Chaoyang Hospital
27 DFS rates
28 Medical University
29 MethodsPatients
30 PurposeThe objective
31 ResultsOne hundred eighty
32 TNT group
33 University
34 advanced rectal cancer
35 adverse events
36 analysis
37 cancer
38 cancer survival
39 chemoradiotherapy
40 chemotherapy
41 complete response rate
42 complications
43 consolidation chemotherapy
44 differences
45 disease-free survival
46 distant metastasis
47 distant metastasis rate
48 effective therapeutic strategy
49 eighties
50 events
51 factors
52 group
53 group differences
54 higher pathological complete response rate
55 hospital
56 impact
57 independent risk factor
58 metastasis
59 metastasis rate
60 multivariate analysis
61 nCRT group
62 neoadjuvant chemoradiotherapy
63 neoadjuvant therapy
64 objective
65 outcomes
66 pathological complete response rate
67 pathological response
68 patients
69 prognosis
70 radical surgery
71 rate
72 rectal cancer
73 rectal cancer survival
74 response
75 response rate
76 retrospective study
77 risk factors
78 similar adverse events
79 strategies
80 study
81 surgery
82 surgical complications
83 survival
84 survival outcomes
85 therapeutic strategies
86 therapy
87 therapy-associated adverse events
88 total neoadjuvant therapy
89 schema:name Impact of total neoadjuvant therapy consisting of consolidation chemotherapy on locally advanced rectal cancer survival
90 schema:pagination 1657-1668
91 schema:productId N667671b7919a4bc1899eeaadb2600729
92 Na4c8bc4c9f5d465e87c7c00576e2d93f
93 Nfbe6ffcb172a40fdba67bd410ba774bf
94 schema:sameAs https://app.dimensions.ai/details/publication/pub.1148785393
95 https://doi.org/10.1007/s00384-022-04179-7
96 schema:sdDatePublished 2022-12-01T06:44
97 schema:sdLicense https://scigraph.springernature.com/explorer/license/
98 schema:sdPublisher N6f252fc1aca64cdfaabf20665eba8ff7
99 schema:url https://doi.org/10.1007/s00384-022-04179-7
100 sgo:license sg:explorer/license/
101 sgo:sdDataset articles
102 rdf:type schema:ScholarlyArticle
103 N028ed16a9be3426fb1a6dda63d0bbfcc rdf:first sg:person.016147501475.43
104 rdf:rest N1b4720b21d5b44a2a6b230623cd2c034
105 N0d00714fc9194045a38ab9c28396a6cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Rectal Neoplasms
107 rdf:type schema:DefinedTerm
108 N12892dfaaf4f49208f2a59760cd0abfa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Antineoplastic Combined Chemotherapy Protocols
110 rdf:type schema:DefinedTerm
111 N17212bc36b0440d7a2b4a3c53ba50614 schema:volumeNumber 37
112 rdf:type schema:PublicationVolume
113 N1b4720b21d5b44a2a6b230623cd2c034 rdf:first sg:person.011747070467.28
114 rdf:rest N3590a5836a694e3da9451dd53b394229
115 N25eacae1ec7143ecaacf665f820b1131 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Oxaliplatin
117 rdf:type schema:DefinedTerm
118 N2d0eaecd772d40a794cc61138819a6bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Chemoradiotherapy
120 rdf:type schema:DefinedTerm
121 N31cc1f5a38234860a9167cc58640e3c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Neoplasm Staging
123 rdf:type schema:DefinedTerm
124 N3590a5836a694e3da9451dd53b394229 rdf:first sg:person.013577637100.39
125 rdf:rest N759188c767d14802ab9dc290afc39809
126 N423681b16ee248cd91a7cb2394f0d13f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Humans
128 rdf:type schema:DefinedTerm
129 N4a0b4a66e36b47e99583765d9a2851cf rdf:first sg:person.01034306452.49
130 rdf:rest rdf:nil
131 N52936efc2d2547fdb3fbfbb6a23d1e65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Retrospective Studies
133 rdf:type schema:DefinedTerm
134 N667671b7919a4bc1899eeaadb2600729 schema:name pubmed_id
135 schema:value 35716183
136 rdf:type schema:PropertyValue
137 N6f252fc1aca64cdfaabf20665eba8ff7 schema:name Springer Nature - SN SciGraph project
138 rdf:type schema:Organization
139 N759188c767d14802ab9dc290afc39809 rdf:first sg:person.0765051075.16
140 rdf:rest N7bc6bafe63fa4ed5a67188325fef85e3
141 N7bc6bafe63fa4ed5a67188325fef85e3 rdf:first sg:person.01155207276.15
142 rdf:rest Ndd01081032ae4bbeb77ae7057b6ee0f9
143 N8b7a7c22982942b58ae175ad5c5d113c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Capecitabine
145 rdf:type schema:DefinedTerm
146 Na2a9cc75d9a6430f849861d855cd6a30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Neoplasms, Second Primary
148 rdf:type schema:DefinedTerm
149 Na4c8bc4c9f5d465e87c7c00576e2d93f schema:name dimensions_id
150 schema:value pub.1148785393
151 rdf:type schema:PropertyValue
152 Na6d39f5ec1294fa3b006a2dee05b84ec rdf:first sg:person.011500603034.71
153 rdf:rest N4a0b4a66e36b47e99583765d9a2851cf
154 Nb747f9d7e39542b794939c4c650aedc9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Consolidation Chemotherapy
156 rdf:type schema:DefinedTerm
157 Nc6025b392ef24e929f75414f4a626b98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Neoadjuvant Therapy
159 rdf:type schema:DefinedTerm
160 Ndaf8e282cca7423183f2d677ef1a41dc schema:issueNumber 7
161 rdf:type schema:PublicationIssue
162 Ndd01081032ae4bbeb77ae7057b6ee0f9 rdf:first sg:person.01260414050.76
163 rdf:rest Na6d39f5ec1294fa3b006a2dee05b84ec
164 Nfbe6ffcb172a40fdba67bd410ba774bf schema:name doi
165 schema:value 10.1007/s00384-022-04179-7
166 rdf:type schema:PropertyValue
167 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
168 schema:name Medical and Health Sciences
169 rdf:type schema:DefinedTerm
170 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
171 schema:name Oncology and Carcinogenesis
172 rdf:type schema:DefinedTerm
173 sg:journal.1096381 schema:issn 0179-1958
174 1432-1262
175 schema:name International Journal of Colorectal Disease
176 schema:publisher Springer Nature
177 rdf:type schema:Periodical
178 sg:person.01034306452.49 schema:affiliation grid-institutes:grid.411607.5
179 schema:familyName Han
180 schema:givenName Jiagang
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034306452.49
182 rdf:type schema:Person
183 sg:person.011500603034.71 schema:affiliation grid-institutes:grid.411607.5
184 schema:familyName Wang
185 schema:givenName Zhenjun
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011500603034.71
187 rdf:type schema:Person
188 sg:person.01155207276.15 schema:affiliation grid-institutes:grid.411607.5
189 schema:familyName Wei
190 schema:givenName Guanghui
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155207276.15
192 rdf:type schema:Person
193 sg:person.011747070467.28 schema:affiliation grid-institutes:grid.411607.5
194 schema:familyName Li
195 schema:givenName Ganbin
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011747070467.28
197 rdf:type schema:Person
198 sg:person.01260414050.76 schema:affiliation grid-institutes:grid.411607.5
199 schema:familyName Qu
200 schema:givenName Hao
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260414050.76
202 rdf:type schema:Person
203 sg:person.013577637100.39 schema:affiliation grid-institutes:grid.411607.5
204 schema:familyName Cao
205 schema:givenName Ke
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013577637100.39
207 rdf:type schema:Person
208 sg:person.016147501475.43 schema:affiliation grid-institutes:grid.411607.5
209 schema:familyName Zhang
210 schema:givenName Haoyu
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016147501475.43
212 rdf:type schema:Person
213 sg:person.0765051075.16 schema:affiliation grid-institutes:grid.411607.5
214 schema:familyName Zhai
215 schema:givenName Zhiwei
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765051075.16
217 rdf:type schema:Person
218 sg:pub.10.1245/s10434-010-0985-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033481932
219 https://doi.org/10.1245/s10434-010-0985-4
220 rdf:type schema:CreativeWork
221 grid-institutes:grid.411607.5 schema:alternateName Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
222 schema:name Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
223 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...